Background: Cell death-inducing DFFA (DNA fragmentation factor-a)-like effector A (CIDEA) is a protein that regulates lipolysis in human adipocytes through cross-talk involving tumor necrosis factor-a (TNF-a). TNF-a downregulates CIDEA mRNA although it is unclear whether this is mediated through transcriptional or post-transcriptional mechanisms. CIDEA has important metabolic effects in human fat cells and genetic variations in the human CIDEA gene have been correlated to the development of obesity. However, little is known about the factors regulating CIDEA expression in human adipocytes. We set out to describe the transcriptional control of human CIDEA. Methods: A 1.1-kb genomic fragment upstream of the transcriptional start site (TSS) of human CIDEA was cloned and deletion fragments were generated. Transcriptional activity of the promoter was analyzed by luciferase reporter assays in in vitrodifferentiated human adipocytes. The effect of TNF-a was assessed in human adipocytes and murine 3T3-L1 cells transfected with deletion fragments of the CIDEA promoter. Protein-DNA interactions were analyzed by electrophoretic mobility shift assays (EMSA). Results: Basal transcriptional activity was found in a 97-bp region upstream of the TSS. We studied the effect of three common haplotypes in the promoter region but found no significant difference in transcriptional activity among them. Incubation of in vitro-differentiated human adipocytes as well as 3T3-L1 cells with TNF-a reduced the transcriptional activity of the human CIDEA promoter, demonstrating a direct effect on CIDEA transcription. EMSAs and mutational analysis indicated that this was mediated by a nuclear factor-kB (NF-kB) site at position À163/À151. Conclusion: We demonstrate that basal transcription of the human CIDEA gene is confined to the 97 first bases upstream of TSS and that TNF-a negatively regulates transcription of this gene, which at least in part involves NF-kB activation.
Introduction
Obesity is associated with dyslipidemia, insulin resistance and type 2 diabetes mellitus. 1 These are all well-documented risk factors for cardiovascular disease. 2 This association is mediated through several mechanisms including altered transcription in human fat cells, which leads to increased release of inflammatory mediators (for example, tumor necrosis factor-a (TNF-a)) and free fatty acids into the circulation (for reviews see 1, 3 ).
We recently showed that cell death-inducing DFFA (DNA fragmentation factor-a)-like effector A (CIDEA) is an important regulator of fat cell metabolism. 4 CIDEA is downregulated in obese patients and CIDEA mRNA levels correlate inversely with markers for the metabolic syndrome in a manner that appears to be human-specific. 4 In a gene profiling study of subcutaneous white adipose tissue (WAT) in obese women following diet-induced weight reduction, CIDEA was the most upregulated gene, 5 indicating a role for CIDEA in body weight regulation. Moreover, a single nucleotide polymorphism (SNP) in exon 4 of CIDEA, C19787G-T, resulting in a V115F amino acid substitution, is associated with body mass index (BMI) in a Swedish cohort of both genders. 6 CIDEA mRNA is downregulated by TNF-a, a cytokine overexpressed in obesity. It is not known whether this is mediated through direct effects on transcription or post-transcriptional mechanisms, for example decreased mRNA stability. Although the molecular action of CIDEA in human adipocytes is not clear, in vitro studies in human adipocytes show that CIDEA inhibits basal lipolysis and TNF-a production in these cells. 4 Thus, CIDEA may regulate insulin sensitivity indirectly through effects on TNF-amediated adipocyte lipolysis. Thus far, little is known regarding the transcriptional regulation of human CIDEA. To date only the transcriptional regulation of the murine CIDEA promoter in liver has been characterized. 7 In this study, we characterized the human CIDEA promoter in human fat cells and 3T3-L1 cells and studied the effect of TNF-a on promoter activity. Furthermore, several SNPs in the 5 0 flanking region of human CIDEA have recently been described 6 and we assessed the effect of the three most common haplotypes in this region on the transcriptional regulation of CIDEA.
Materials and methods
Cell cultures and patient samples Subcutaneous adipose tissue was obtained from healthy patients undergoing elective cosmetic liposuction. The study was approved by the ethical committee at Karolinska University Hospital and informed consent was obtained from each patient. We certify that all applicable institutional and governmental regulations concerning the ethical use of human volunteers were followed during this research. Experiments were performed in in vitro-differentiated human adipocytes derived either from human mesenchymal stem cells (hMSCs) or from human preadipocytes isolated from adipose tissue. Isolation, culture and differentiation of hMSCs and of human preadipocytes were performed as described previously. 8, 9 In vitro-differentiated hMSCs are somewhat sensitive to transfections and concomitant TNF-a treatments. For transfection studies with simultaneous TNF-a incubations, our analyses were therefore complemented with experiments in the well-established murine adipocyte cell line 3T3-L1. These cells were cultured as described. 10 5 0 rapid amplification of cDNA ends (5 0 RACE), cloning and mutagenesis A 5 0 RACE study was performed to identify the CIDEA transcriptional start site (TSS). CIDEA mRNA 5 0 ends were amplified from Human Adipocyte and Adipose Tissue Marathon-Ready cDNA (Clontech, Mountain View, California, USA) with the CIDEA-specific primer 5 0 -ATGCGTGTTGTCT CCCAAGGTCTGA-3 0 and nested primer 5 0 -CAGAGTGACC AGTCCGGTAGCGATG-3 0 using the Advantage 2 Polymerase Mix (Clontech) according to the manufacturer's instructions. The PCR products were gel purified and ligated into a pGEM T Easy-vector (Promega, Madison, Wisconsin, USA). Ligations were transformed into competent bacteria and plated onto appropriate antibiotic-containing plates from which colonies were inoculated. DNA was isolated with a kit from Qiagen GmbH (Hilden, Germany) standard protocol. DNA sequencing confirmed the identities of all clones.
CIDEA promoter reporter constructs were generated by amplifying a 1.1-kb fragment of the 5 0 region of human CIDEA (from À1124 to þ 2 relative to the TSS) by PCR using Pfu DNA polymerase (Promega). The amplified fragments were cloned into the pGL3-basic vector (Promega). Constructs were verified by DNA sequencing (MWG Biotech, Germany).
Site directed mutagenesis of the SNP rs7230534, located at À635 relative to the TSS, and of a putative nuclear factorkB (NF-kB) binding site located at À163/À151 was performed using QuikChange II Site-Directed Mutagenesis Kit (Stratagene, La Jolla, California, USA). The sequences for the forward primers used in the mutagenesis were as follows (bold letters indicate mutated bases and the putative binding site for NF-kB is underlined): 5 0 -CATGCAGTCCAAAGGTTC CTTTCCCCTCCCG-3 0 and 5 0 -CCAGGACGACCTTGGGCTC AAAGAGCGCGAAGTCGCGATC-3 0 respectively. The reverse primer was complementary to these sequences.
Transient transfection
In vitro-differentiated human adipocytes were transfected as described in detail previously.
11 3T3-L1 cells were transfected at 80% confluence with 0.5 mg of reporter DNA and 0.1 mg of CMV-b-galactosidase-containing vector using 2 ml lipofectamine and 8 ml plus reagent (Invitrogen, Carlsbad, CA, USA). At 24 h post-transfection, cells were incubated in differentiation medium with or without 10 mM of the peroxisome proliferator-activated receptor gamma (PPARg) agonist BRL49653 or TNF-a (50 ng/ml) (Sigma, St Louis, MO, USA) for an additional 24 h, respectively. 3T3-L1 cells and in vitrodifferentiated human adipocytes were lysed and luciferase and b-galactosidase activity were measured according to the manufacturer's protocol (Luciferase Assay System and b-Galactosidase Enzyme Assay System, both from Promega) using an infinite 200 luminometer (Tecan, Salzburg, Austria). Luciferase activity was normalized for b-galactosidase activity and experiments with high variability in b-galactosidase activity were excluded. All experiments were run in triplicate and repeated at least four times with similar results. without unlabeled probe (200-fold excess of either probe À242/À202 or À202/À151). In addition, another unlabeled probe was used comprising À202/À151 with a mutated NF-kB site (À163/À151). Two microliters of the 32 P-labeled probe (10 000 cpm ml
À1
) was added and the sample was incubated 30 min at room temperature. Reaction mixtures were analyzed at 41C on 4% polyacrylamide gels in 50 mM Tris base/45 mM boric acid/0.5 mM EDTA. The gel was dried and developed in a Hypercassette (Amersham, UK) with an intensifying screen (Kodak, Rochester, New York, USA). The sequences for the oligonucleotides/probes used were as follows (a putative binding site for NF-kB is underlined and mutated bases are shown in bold letters): À242/À202:
and À202/À151: 5 0 -GAAGGACGCGCGGCTCC AGGCTGCGGGAGCCAGGACGACCGGGGGCTCCCAG-3 0 as well as mutated À202/À151 GAAGGACGCGCGGCTC CAGGCTGCGGGAGCCAGGACGACCTTGGGCTCAAAG-3 0 . Complementary oligonucleotides to À242/À202, À202/ À151 and mutated À202/À151 were used to create double stranded probes.
Statistical analyses
Statistical differences were determined by nonparametric methods. Different groups were compared using Mann-Whitney U test. P-values are indicated when appropriate and P-values less than 0.05 were considered statistically significant.
Results
Identification of the transcriptional start site of the human CIDEA gene Using 5 0 RACE we identified a single transcript of CIDEA in human adipocytes with the TSS at nucleotide A, 14-bp upstream of the translational start codon ATG ( Figure 1a ). This identified transcript corresponds to the previously published CIDEA transcript NM_001279. The alternative CIDEA transcript NM_198289, which contains another exon 1, was not detected in our cDNA libraries.
Bioinformatic comparison of the putative human adipose promoter sequence and the murine liver CIDEA promoter Using the Hamming-Clustering Method for TATA Signal Prediction in Eukaryotic Genes (http://www.itb.cnr.it/sun/ webgene/) from WebGene, we identified putative TATAboxes in a 2.1-kb-long sequence upstream of the human CIDEA translation initiation codon ATG (NT_010859). The TATA-box closest to the TSS was predicted at À40/À31 (TTTAAGAGGC) (Figure 1a) . A corresponding TATA-box sequence was also predicted in the murine 5 0 UTR. We compared the human CIDEA sequence, 2.0-kb upstream of ATG (NT_010859), with that of a region comprising 3.0-kb upstream of the translation initiation codon of the corresponding mouse sequence (EF451058) and the corresponding predicted rat sequence using zPicture (http://zpicture.dcode.org/). The analyzed sequences include the 14-bp 5 0 UTR and the putative promoter region for human CIDEA and the 745-bp-long 5 0 UTR and promoter region of the murine CIDEA. Using a threshold of at least 70% identity over 100-bp, no evolutionarily conserved regions (ECRs) shared between the rat, mouse and human promoter regions were identified. However, ECRs between mouse, rat and human were found when threshold was set to 80% over 20-bp (Figure 1a ). These ECRs are located in the 5 0 UTR of the murine CIDEA transcript 7 or in the human promoter between À811 and À61. We also analyzed the two promoters for CpG islands with CpG Island Searcher (http:// www.uscnorris.com/cpgislands2/). Using a 55% limit for GCcontent and a length of at least 500-bp, one CpG island in the human promoter (À607/ þ 21) as well as one island in the murine 5 0 UTR ( þ 183/ þ 784) was predicted. These regions overlap with the ECRs predicted by the zPicture.
The human CIDEA sequence was analyzed for putative transcription factor binding sites using MatInspector software from Genomatix BiblioSphere (Figure 1b) . Core similarity was set to 0.75. Consensus sequences for, among others, the vitamin D receptor (VDR), Sp1 and NF-kB were predicted in the promoter region.
The minimal promoter for transcription of CIDEA is present within 97-bp from the transcriptional start site To identify the minimal promoter region needed for transcription, we cloned a 1.1-kb-long region from À1124 to þ 2 of TSS of CIDEA. We generated eight fragments (A-H) with deleted 5 0 ends and tested their transcriptional activity in a luciferase reporter system in in vitro-differentiated human adipocytes. The activity for all deletion fragments was significantly higher (A: Po0.001; B: Po0.01; C: Po0.001; D: Po0.001; E: Po0.001; F: Po0.001; G: Po0.001 and H: Po0.05) than that of cells transfected with empty vector alone (Figure 2a ). The highest activity was observed with fragments C (À325/ þ 2), D (À279/ þ 2), E (À244/ þ 2) and F (À123/ þ 2), whereas fragment A (À1124/ þ 2) and B (À409/ þ 2) displayed a significantly lower activity compared with fragment C, D, E and F. Furthermore, the transcriptional activity of the shortest fragment H (À46/ þ 2) was significantly different from fragment G (À97/ þ 2) (Po0.05) as well as the other mutation fragments, indicating that most of the transcriptionally important elements Effect of SNPs in the human CIDEA 5 0 flanking region We investigated the effect on transcription of five common SNPs, highlighted in Figure 1b , in the 5 0 flanking region of CIDEA, which form three common haplotypes that were described previously. 6 In vitro-differentiated human adipocytes were transfected with reporter constructs containing three different haplotypes. However, we observed no difference in luciferase activity among the constructs (Figure 2b ).
TNF-a, but not PPARg agonists, regulates human CIDEA promoter activity CIDEA mRNA expression is downregulated in vitro by TNF-a.
To define putative TNF-a-regulated regions, we studied the effect of TNF-a on human fat cells transfected with promoter construct A (À1124/ þ 2). Luciferase assays in in vitrodifferentiated human adipocytes demonstrated that TNF-a significantly reduced the transcriptional activity of this construct (Figure 2c ). We and others have previously shown that TNF-a promotes a slight increase in human adipocyte apoptosis in culture. 13, 14 This effect is somewhat more pronounced in cells subjected to concomitant transfections which preclude firm conclusions when differences among promoter constructs are studied. We therefore used the wellestablished murine cell line 3T3-L1 to investigate the TNF-amediated regulation of the human CIDEA promoter in more detail. Similar to the findings in human adipocytes, TNF-a attenuated the transcriptional activity of the CIDEA promoter in murine 3T3-L1 cells (Figure 3a , left panel). Moreover, this effect was specific, as incubation with the PPARg agonist BRL49653 did not result in any significant difference in transcriptional activity (Figure 3a , right panel).
To further investigate the TNF-a-induced regulation of the CIDEA promoter, 3T3-L1 cells were transfected with the previously generated deletion fragments followed by incubations with TNF-a for 24 h. Luciferase assays demonstrated that the TNF-a effect was confined to the region À244/À123, which includes a binding site for NF-kB (À163/À151) (Figure 3b ). We mutated this binding site in fragment E (À244/ þ 2) and transfected 3T3-L1 cells with either wild type (wt) or mutated (mut) fragment. The attenuating effect of TNF-a treatment was significantly reduced in cells transfected with the mutated promoter fragment compared with cells treated with wt fragments (Figure 3c ), suggesting that this site is important for TNF-a regulation in vivo.
Finally, to investigate the transcription factor binding ability of this region, we studied DNA-protein interactions by EMSAs using two double-stranded oligonucleotide probes comprising the region between À242/À202 and À202/À151, respectively. TNF-a treatment of in vitro-differentiated human adipocytes resulted in an increased binding of proteins to probe À202/À151 which was blocked by pre-incubation with an excess of unlabeled probe À202/À151 (Figure 4) . In contrast, no binding was observed using probe À242/À202 (data not shown). Oligonucleotide À202/À151 comprises one NF-kB binding site (À163/À151) predicted by MatInspector. To assess whether NF-kB could bind to this region we pretreated human adipocytes with a peptide (WP) that inhibits NF-kB signaling. This resulted in a loss of the lower protein complex, whereas pretreatment with a mutated, biologically inactive form of the peptide (MP) did not affect this interaction. Incubation with WP or MP alone Transcriptional control of human CIDEA AT Pettersson et al had no effect on nuclear translocation of NF-kB, adipocyte survival or differentiation.
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Discussion
In this study we have characterized the 5 0 flanking region of human CIDEA in adipocytes. We were able to define the TSS for CIDEA and the presence of one single transcript in human adipocytes as demonstrated by 5 0 RACE. This identified transcript corresponds to the previously published CIDEA transcript NM_001279. Furthermore, we analyzed transcriptional activity in a 1.1-kb genomic region upstream of the TSS of CIDEA. The shortest deletion fragment (À46/ þ 2) displayed a significantly lower transcriptional activity compared with the longer fragments, indicating that basal activity of CIDEA is confined to a 97-bp-long sequence upstream of the TSS. We therefore suggest that the core promoter for human CIDEA is found À97 to þ 2 relative to the TSS and that the region À97/À46 is critical for transcriptional activity of the gene. In addition, we found that the region between À325 and À97 was more transcriptionally active than the region À1125 to À325 indicating that transcription activating elements are present in the more proximal portion, whereas repressing elements may be Transcriptional control of human CIDEA AT Pettersson et al located in the more distal part of the CIDEA promoter. During the preparation of this manuscript Li et al. 15 published a study on the tissue-specific expression of human CIDEA. Although the focus in that work is different than that in our present study, Li et al., describe a core promoter of human CIDEA that corresponds to the one we described herein. The murine CIDEA promoter was recently described in liver cells 7 and we therefore compared the 5 0 flanking region of the human CIDEA with the murine promoter. Interestingly, the murine sequence contains a long (approx 745-bp) 5 0 UTR from the TSS to the ATG, whereas the corresponding human sequence is only 14-bp. Shift of the TSS to a more 3 0 end of the gene could indicate a species-specific change in gene regulation. It could be speculated that transcription factor binding sites close to the translational start site are important for CIDEA regulation in human white adipocytes. These could shift the TSS closer to translation, leaving a short 5 0 UTR. Alternatively, the length of the 5 0 UTR could influence mRNA stability, which could be another important mechanism of CIDEA regulation.
CpG island are regions in the genome with a high frequency of cytosine-guanine (CG) dinucleotides. These regions typically occur at or near TSS of genes. Methylation of the cytosine in CG dinucleotides represses transcription and CpG islands are therefore implicated in the regulation of gene expression. We found ECRs in the human as well as in the murine promoter that overlapped with CpG islands suggesting that these regions are of importance in the regulation of CIDEA. In the recent study by Li et al. 15 they demonstrate that the ubiquitously expressed transcription factors Sp1 and Sp3 as well as DNA methylation in a CpG island is important for differential CIDEA expression. This CpG island spans the 5 0 upstream region as well as parts of exon 1 of the human CIDEA and corresponds to the CpG island we found in our human sequence.
CIDEA expression in human adipose tissue correlates inversely with different clinical parameters of insulin resistance. 4 It is therefore possible that genetic differences in the transcriptional regulation of this gene may be of importance for weight regulation and/or insulin sensitivity. A set of SNPs in the 5 0 flanking region of the CIDEA sequence were recently described and could putatively influence transcriptional regulation of CIDEA. However, when analyzing the reporter gene activity of the three most common haplotypes we could not detect any significant difference, suggesting that the SNPs analyzed in this context do not play any major part in transcriptional regulation. Admittedly, we cannot exclude the possibility that the promoter SNPs might be of importance in vivo when linked to other coding as well as noncoding polymorphisms. It is also possible that the effect of the different haplotypes on the CIDEA promoter is too small to be detected in our assays.
The murine liver CIDEA promoter contains a set of PPAR response elements (PPREs) critical for transcriptional regulation. 7 Moreover, PPARg is essential for adipocyte differentiation and regulates CIDEA expression in murine liver. 7 We therefore analyzed the putative human promoter CIDEA sequence for possible PPRE elements and tested the effect of the PPARg agonist BRL49653 on murine adipocytes transfected with the CIDEA promoter. By bioinformatic analysis, we could not detect any PPREs in the human sequence. Moreover, the PPARg agonist BRL49653 did not affect the transcriptional activity in 3T3-L1 cells transfected with the human promoter. Therefore, at least the part of the human promoter studied here, does not seem to be directly regulated by PPARs. These differences between the murine and human CIDEA promoter could account for the speciesspecific expression pattern of CIDEA, where the gene in mice, in contrast to humans, is predominantly expressed in brown but not in white adipose tissue. Finally, we studied the effects of TNF-a on CIDEA expression. TNF-a suppressed the activity of the luciferase reporter driven by the CIDEA promoter in both murine and human adipocytes and we therefore conclude that TNF-a directly controls CIDEA transcription. In our system, TNF-a regulation of transcription was confined to the region À244/ À123 upstream of the TSS This region contains a consensus sequence for NF-kB (À163/À151) a transcription factor regulated by TNF-a. Our EMSA experiments demonstrate that TNF-a induces protein binding to the probe À202/À151 encompassing the NF-kB site. We tested two commercially available antibodies for NF-kB proteins (p50 and p65), but were unable to detect any super shifts on the EMSAs (data not shown). It is however still possible that the DNA-protein complex is composed of other members of the NF-kB family. This would be in line with the finding that protein binding to probe À202/À151 is abolished with a specific NF-kB inhibitor, WP. WP is a well characterized NBD peptide that has been shown to selectively inhibit NF-kB activation induced by proinflammatory cytokines in several in vitro and in vivo systems. 12, 16, 17 Furthermore, when the NF-kB site is mutated, the inhibitory effect of TNF-a on CIDEA promoter activity is attenuated. Taken together these data suggest that TNF-a, at least in part, mediates it's action on CIDEA transcriptional regulation through this (and possibly other) NF-kB binding site(s). Nevertheless, our results do not preclude that yet other transcription factors may be involved in the negative regulation of CIDEA by TNF-a. It is interesting to note that TNF-a has previously been shown to regulate CIDEA expression through the c-Jun N-terminal kinase (JNK). 4 JNK phosphorylates and activates homodimers or heterodimers of c-jun and/or c-fos proteins termed AP-1 which act as transcription factors binding to AP-1 regulatory elements in the promoter regions of several mammalian genes. 18 Although we could not detect any AP-1 consensus sequences in the human CIDEA promoter using MatInspector, another software (AliBaba 2.1, TRANSFAC) predicted one putative AP-1 site at position À270/À258. However, mutation or deletion of this site did not affect transcriptional regulation or modulation by TNF-a (data not shown), suggesting that JNK may either affect CIDEA transcription through indirect mechanisms probably In conclusion, we have identified the TSS for human CIDEA and the minimal promoter needed for transcription. Furthermore, we demonstrate that three common haplotypes in the CIDEA promoter appear to be of little importance for transcriptional activity of the gene, at least in vitro. Finally, we have also defined a region in the CIDEA promoter regulated by TNF-a, which most probably involves NF-kB activation. These results are an important basis for further studies of CIDEA in human adipocytes and may also enable the development of substances that would increase CIDEA expression, which could be of clinical importance in the treatment of a number of metabolic disorders.
